Health Care: Drugs

Arqule Inc (ARQL: NASDAQ)

$1.32 0.03 | 2.33%
08/29/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 1.32
52 Week High 2.94
52 Week Low 1.24
Avg. Daily Vol. (Mil) 0.49
Beta (3 year) 1.03
Share Related Items
Mkt Cap (Mil) 82.86
Shares Out (Mil) 62.77
Float (Mil) 56.86
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.00
Current Ratio 3.10
LT Debt/ Equity 0.00
Total Debt / Equity 0.03
Valuation Ratios
Price Earnings n.a.
Price/Sales 7.27
Price/Book 1.69
Price/Cash Flow -3.50
Per Share Data
Earnings -0.41
Sales 0.18
Book Value 0.78
Cash Flow -0.38
Business Summary
ArQule, Inc., is a clinical-stage biotechnology company engaged in the research and development of innovative cancer therapeutics.
General Information
19 Presidential Way
Woburn, MA 01801
www.arqule.com
Industry : Drugs
Sector: Health Care
Employees: 40
CEO: Paolo Pucci
Short Interest
Current Month (Mil) 0.82
Previous Month (Mil) 0.81
Short Interest Ratio (Days) 3.40
Management Effectiveness
Return on Equity n.a.
Return on Assets -31.80
Return on Investments -52.00
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with ARQL

Latest ARQL Headlines from TheStreet

More Financial News for ARQL

Press Releases for ARQL

See All Press Releases

Partner Headlines for ARQL

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter